HomeRibavirinRibavirin + Lamivudine And Zidovudine

Does Ribavirin Interact with Lamivudine And Zidovudine?

Ribavirin and Lamivudine And Zidovudine have a contraindicated drug interaction according to U.S. FDA drug labeling data. Antagonistic relationship with zidovudine demonstrated in vitro; concomitant use should be avoided. Also may increase hematologic toxicity of zidovudine. The mechanism involves antagonistic interaction; bone marrow suppression. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Ribavirin Class
Nucleoside Analog Antiviral
Lamivudine And Zidovudine Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ribavirin and Lamivudine And Zidovudine occurs because antagonistic interaction; bone marrow suppression. Clinically, this means antagonistic relationship with zidovudine demonstrated in vitro; concomitant use should be avoided. also may increase hematologic toxicity of zidovudine. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Ribavirin and your doctor is considering prescribing Lamivudine And Zidovudine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ribavirin(Moderiba)+💊 Lamivudine And Zidovudine(Combivir)

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Nucleoside Analog Antiviral
Drug B class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Source
NLP:lamivudine and zidovudine

What this means in plain English

Antagonistic relationship with zidovudine demonstrated in vitro; concomitant use should be avoided. Also may increase hematologic toxicity of zidovudine.

About Ribavirin and Lamivudine And Zidovudine

Ribavirin is a Nucleoside Analog Antiviral, while Lamivudine And Zidovudine is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Moderiba and Combivir. Ribavirin is inhaled, whereas Lamivudine And Zidovudine is taken by mouth. Both Ribavirin and Lamivudine And Zidovudine carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Antagonistic interaction; bone marrow suppression"

📖 Source: NLP:lamivudine and zidovudine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ribavirin and Lamivudine And Zidovudine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.